Atıf Formatları
Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Akagunduz Et Al. , "Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer," Journal of Geriatric Oncology , vol.14, no.2, 2023

Akagunduz, B. Et Al. 2023. Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer. Journal of Geriatric Oncology , vol.14, no.2 .

Akagunduz, B., Guven, D. C., Ozer, M., Okten, I. N., Atag, E., Unek, İ. T., ... TATLI, A. M.(2023). Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer. Journal of Geriatric Oncology , vol.14, no.2.

Akagunduz, Baran Et Al. "Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer," Journal of Geriatric Oncology , vol.14, no.2, 2023

Akagunduz, Baran Et Al. "Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer." Journal of Geriatric Oncology , vol.14, no.2, 2023

Akagunduz, B. Et Al. (2023) . "Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer." Journal of Geriatric Oncology , vol.14, no.2.

@article{article, author={Baran Akagunduz Et Al. }, title={Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer}, journal={Journal of Geriatric Oncology}, year=2023}